Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98201-98250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04684862
Infusion System for Hepatic Cancer
NARecruiting
100 participants
Started: Feb 8, 2021 · Completed: Jul 31, 2029
2 conditions1 sponsor1 location
NCT04714840
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
NAActive, not recruiting
181 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04222504
Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot
NARecruiting
500 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT04804202
Virtual Cycling Environments for Persons With Parkinson Disease
NARecruiting
60 participants
Started: Feb 8, 2021 · Completed: Dec 30, 2026
1 condition3 sponsors2 locations
NCT04545151
Verapamil SR in Adults With Type 1 Diabetes
PHASE2Active, not recruiting
138 participants
Started: Feb 8, 2021 · Completed: May 31, 2026
1 condition2 sponsors22 locations
NCT04793867
Regional Phenotyping of CF and Non-CF Bronchiectasis
N/ARecruiting
100 participants
Started: Feb 8, 2021 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT04798690
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
N/ARecruiting
2,500 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2031
4 conditions1 sponsor1 location
NCT04134598
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
PHASE3Active, not recruiting
926 participants
Started: Feb 8, 2021 · Completed: Mar 31, 2030
1 condition2 sponsors1 location
NCT06117410
Assessing Ultrasonographic Severity of Adenomyosis
N/ARecruiting
200 participants
Started: Feb 8, 2021 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT04315324
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
PHASE1/PHASE2Recruiting
67 participants
Started: Feb 8, 2021 · Completed: Aug 1, 2028
4 conditions2 sponsors163 locations
NCT04885504
Post COVID-19 Biorepository
N/ARecruiting
100 participants
Started: Feb 8, 2021 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT04736173
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
PHASE2Active, not recruiting
169 participants
Started: Feb 8, 2021 · Completed: May 31, 2027
4 conditions2 sponsors92 locations
NCT04564677
A Study Evaluating the Clinical Outcome of a Modified d'Hoore Technique for Laparoscopic Ventral Mesh Rectopexy
N/ARecruiting
150 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04640779
Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
39 participants
Started: Feb 8, 2021 · Completed: Aug 15, 2027
8 conditions2 sponsors1 location
NCT04574960
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
PHASE3Recruiting
14 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2027
2 conditions2 sponsors2 locations
NCT04681469
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
PHASE2Recruiting
49 participants
Started: Feb 8, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT06782776
Role of Doppler Echoflowmetry to Define Risk Factors for the Development of Complications in Twin Pregnancies
N/ARecruiting
6,600 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04776434
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
NAActive, not recruiting
723 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor27 locations
NCT04663100
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
NARecruiting
30 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2023
4 conditions3 sponsors1 location
NCT05839834
Blood Cell RNA-Based Cancer Detection
N/ARecruiting
5,000 participants
Started: Feb 8, 2021 · Completed: Dec 8, 2024
2 conditions1 sponsor1 location
NCT04229979
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
PHASE3Active, not recruiting
127 participants
Started: Feb 8, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors73 locations
NCT04272515
Molecular Characterization for Understanding Biliary Atresia
NARecruiting
100 participants
Started: Feb 7, 2021 · Completed: Feb 7, 2032
1 condition1 sponsor2 locations
NCT04145258
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
PHASE3Recruiting
768 participants
Started: Feb 7, 2021 · Completed: Apr 30, 2026
1 condition3 sponsors13 locations
NCT04515524
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
N/AActive, not recruiting
100 participants
Started: Feb 5, 2021 · Completed: Nov 5, 2026
1 condition1 sponsor30 locations
NCT04387734
Effects of Ocrevus in Relapsing Multiple Sclerosis
PHASE4Active, not recruiting
60 participants
Started: Feb 5, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT03541889
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
PHASE1Recruiting
56 participants
Started: Feb 5, 2021 · Completed: Nov 30, 2027
1 condition5 sponsors4 locations
NCT04454203
Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension
PHASE4Recruiting
40 participants
Started: Feb 5, 2021 · Completed: Feb 3, 2026
4 conditions1 sponsor1 location
NCT04782830
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
NARecruiting
29 participants
Started: Feb 5, 2021 · Completed: Oct 1, 2027
5 conditions1 sponsor1 location
NCT04739696
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.
NAActive, not recruiting
510 participants
Started: Feb 5, 2021 · Completed: Sep 30, 2026
4 conditions2 sponsors1 location
NCT05097820
Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants
N/ARecruiting
100 participants
Started: Feb 5, 2021 · Completed: Dec 31, 2030
8 conditions2 sponsors1 location
NCT05536817
Sleep Disorder in Inflammatory Bowel Disease and Its Association With Disease Activity
N/ARecruiting
100 participants
Started: Feb 5, 2021 · Completed: Feb 29, 2024
2 conditions1 sponsor1 location
NCT04532606
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
PHASE4Recruiting
1,128 participants
Started: Feb 5, 2021 · Completed: Oct 31, 2026
5 conditions6 sponsors6 locations
NCT04103554
Sacubitril/Valsartan in Left Ventricular Assist Device Recipients
PHASE4Active, not recruiting
60 participants
Started: Feb 5, 2021 · Completed: Feb 28, 2025
1 condition1 sponsor6 locations
NCT05490745
Psychological Intervention for Child Mental Health Based on Parental Reflective Functioning to Enhance Positive Parenting
NARecruiting
60 participants
Started: Feb 4, 2021 · Completed: Dec 31, 2025
2 conditions5 sponsors1 location
NCT04567615
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
PHASE2Active, not recruiting
266 participants
Started: Feb 4, 2021 · Completed: Oct 3, 2025
5 conditions1 sponsor65 locations
NCT04340258
Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Feb 4, 2021 · Completed: Sep 4, 2025
1 condition2 sponsors2 locations
NCT04749836
Outcomes and Safety of Various Conduction System Pacing Methods
N/ARecruiting
150 participants
Started: Feb 4, 2021 · Completed: Dec 1, 2024
3 conditions1 sponsor1 location
NCT04341779
Simplifying Treatment and Monitoring for HIV (STREAM HIV)
NAActive, not recruiting
539 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2025
2 conditions3 sponsors1 location
NCT04901936
A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PHASE2Recruiting
12 participants
Started: Feb 4, 2021 · Completed: Dec 31, 2028
2 conditions1 sponsor12 locations
NCT04447911
Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
PHASE4Recruiting
172 participants
Started: Feb 4, 2021 · Completed: Feb 28, 2026
4 conditions3 sponsors3 locations
NCT04699123
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
PHASE2Active, not recruiting
159 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT05388708
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
N/ARecruiting
550 participants
Started: Feb 4, 2021 · Completed: Sep 30, 2027
2 conditions2 sponsors99 locations
NCT04742387
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
N/AActive, not recruiting
40 participants
Started: Feb 4, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04431726
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
PHASE3Active, not recruiting
55 participants
Started: Feb 4, 2021 · Completed: May 18, 2030
1 condition1 sponsor31 locations
NCT04583254
Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study
PHASE2Recruiting
48 participants
Started: Feb 4, 2021 · Completed: Dec 14, 2028
1 condition2 sponsors3 locations
NCT04799119
Multi-site Animal Assisted Intervention for Children With DD and Their Family Dog
NAActive, not recruiting
100 participants
Started: Feb 4, 2021 · Completed: Aug 29, 2025
2 conditions1 sponsor1 location
NCT04190550
Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
PHASE1Active, not recruiting
24 participants
Started: Feb 4, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor6 locations
NCT04503772
Preoperative Stereotactic Radiosurgery for Brain Metastases
PHASE2Active, not recruiting
70 participants
Started: Feb 4, 2021 · Completed: Apr 30, 2026
1 condition2 sponsors8 locations
NCT04458402
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer
NAActive, not recruiting
15 participants
Started: Feb 4, 2021 · Completed: Jul 4, 2026
1 condition1 sponsor1 location
NCT04075240
VTE Prevention Following Total Hip and Knee Arthroplasty
PHASE3Recruiting
5,400 participants
Started: Feb 4, 2021 · Completed: Apr 30, 2026
1 condition4 sponsors1 location